1
Clinical Trials associated with CC-EIEs(Shenzhen Geno-Immune Medical Institute) / Unknown statusPhase 1/2IIT Innovative Treatment of Cervical Cancer Using Engineered Antigen-specific Immune Effectors (EIEs)
The primary objective of this study is to evaluate the safety of cervical cancer specific engineered immune effectors (CC-EIEs). The secondary objectives are to evaluate the rate of successful CC-EIE generation in vitro and determine the anti-CC efficacy.
100 Clinical Results associated with CC-EIEs(Shenzhen Geno-Immune Medical Institute)
100 Translational Medicine associated with CC-EIEs(Shenzhen Geno-Immune Medical Institute)
100 Patents (Medical) associated with CC-EIEs(Shenzhen Geno-Immune Medical Institute)
100 Deals associated with CC-EIEs(Shenzhen Geno-Immune Medical Institute)